Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model

References

• Ali, M. F., Salah, M., Rafea, M., Saleh, N. (2008). Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization, and laser targeting. Med Sci Monit 14:166–174.
   Web of Science ®Google Scholar
• Barker, J. N. (1991). The pathophysiology of psoriasis. Lancet 338:227–230.
   PubMed Web of Science ®Google Scholar
• Bleicher, P. A. (1993). T lymphocytes in psoriasis. J Invest Dermatol 101:695–700.
   PubMedGoogle Scholar
• Brady, S. P. (2004). Parakeratosis. J Am Acad Dermatol 50:77–84.
   PubMedGoogle Scholar
• Brown, W. R., Rogozinski, T. T., Ramsay, C. A. (2006). Anthralin and tar with UVB increases epidermal cell proliferation in asebia mice. Clin Exp Dermatol 13:248–251.
   Google Scholar
• Danilenko, D. M. (2008). Animal models of human disease: preclinical models of psoriasis. Vet Pathol 45:563–575.
   PubMed Web of Science ®Google Scholar
• Dawn, A., Yosipovitch, G. (2006). Treating itch in psoriasis. Dermatol Nurs 18:227–233.
   PubMedGoogle Scholar
• Fujii, M., Takeda, Y., Yoshida, M., Utoguchi, N., Matsumoto, M., Watanabe, Y. (2003). Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int J Pharm 258:217–223.
   PubMedGoogle Scholar
• Hadgraft, J., Guy, R. H. (2003). Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Hadgraft, J., Guy, R. H. (Eds.), Transdermal drug delivery: development issues and research initiatives, vol 123 (pp 1–24). New York: Marcel Dekker.
   Google Scholar
• Ho, H-O., Chen, L-C., Lin, H-M., Sheu, M-T. (1998). Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. J Contr Rel 51(2–3):301–311.
   PubMedGoogle Scholar
• Jain, A. K., Thomas, N. S., Panchagnula, R. (2002). Transdermal drug delivery of imipramine hydrochloride, effect of terpenes. J Contr Rel 79:93–101.
   PubMed Web of Science ®Google Scholar
• Lakshmi, P. K., Devi, G. S., Bhaskaran, S., Sacchidanand, S. (2007). Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Ind J Dermatol Venereol Leprol 73:157–161.
   PubMed Web of Science ®Google Scholar
• Leigh, I. M., Pulfordf, K. A., Ramaekers, F. C. S., Lane, E. B. (1985). Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol 113:53–64.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Ye, X., Feng, X., Zhou, G., Rong, Z., Fang, C., et al. (2005). Menthol facilitates the skin analgesic effect of tetracaine gel. Int J Pharm 305(1–2):31–36.
   PubMedGoogle Scholar
• Maghraby, E., Gemel, M. M., Adrian, C. W., Brain, W. B. (2006). Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415–429.
   PubMed Web of Science ®Google Scholar
• Nakaguna, H., Kambara, T., Yamamoto, T. (1995). Rat ultravoilet ray B photodermatitis: an experimental model of psoriasis vulgaris. Int J Exp Pathol 76:65–73.
   PubMedGoogle Scholar
• Pershing, L. K., Lambert, L. D., Knutson, K. (1990). Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res 7:170–175.
   PubMed Web of Science ®Google Scholar
• Sasaki, H., Kojima, M., Mori, Y., Nakamura, J., Shibasaki, J. (1991). Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen. J Pharm Sci 80:533–538.
   PubMed Web of Science ®Google Scholar
• Shokria, J., Nokhodchi, A., Dashbolaghia, A., Hassan-Zadeha, D., Ghafourianb, T., Barzegar Jalali, M. (2001). The effect of surfactants on the skin penetration of diazepam. Int J Pharm 228:99–107.
   PubMedGoogle Scholar
• Sinha, V. R., Kaur, M. P. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131–1140.
   PubMed Web of Science ®Google Scholar
• Skelly, J. P., Shah, V. P., Maibach, H. I., Guy, R. H., Wester, R. C., Flynn, G., et al. (1987). FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm Res 4:265–267.
   Web of Science ®Google Scholar
• Spearman, R. I. C., Hardy, J. A. (1977). Ultrastructure of the contrasting types of keretinization seen in the tail epidermis of the laboratory mouse Mus musculens. Arch Dermatol Res 258:33–40.
   PubMedGoogle Scholar
• Stratis, A., Pasparakis, M., Rupec, R. A., Markur, D., Hartmann, K., Scharffetter-Kochanek, K., et al. (2006). Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 116:2094–2104.
   PubMed Web of Science ®Google Scholar
• Sutton, L., Swinehart, J. M., Cato, A., Kaplan, A. S. (2001). A clinical study to determine the efficacy and safety of 1% methotrexate/azone (MAZ) gel applied topically once-daily in patients with psoriasis vulgaris. Int J Dermatol 40:464–467.
   PubMed Web of Science ®Google Scholar
• Tekade, R. K., Dutta, T., Tyagi, A., Bharti, A. C., Das, B. C., Jain, N. K. (2008). Surface-engineered dendrimers for dual drug delivery: A receptor upregulation and enhanced cancer targeting strategy. J Drug Targ 16:758–772.
   PubMed Web of Science ®Google Scholar
• Vanaja, K., Shobha Rani, R. H., Sacchidananda, S. (2008). Formulation and clinical evaluation of ultradeformable liposomes in the topical treatment of psoriasis. Clin Res Regul Aff 25:41–52.
   Google Scholar
• Weinstein, G. D., McCullough, J. L., Olsen, E. (1989). Topical MTX therapy for psoriasis. Arch Dermatol 125:227–230.
   PubMed Web of Science ®Google Scholar
• Wrench, R., Britten, A. (1975). Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. III. High boiling tar oil acids. Br J Dermatol 93:67–73.
   PubMedGoogle Scholar